What EU-GMP Means for Medical Cannabis
EU-GMP — European Good Manufacturing Practice — is the gold standard for pharmaceutical production across the European Union and is recognised globally as a benchmark for medicinal product quality. For medical cannabis, EU-GMP certification means that every step of the cultivation, extraction, processing, testing, and packaging process has been validated, audited, and approved by a competent national authority.
In practice, EU-GMP certification for cannabis is granted under EU Directive 2001/83/EC and EudraLex Volume 4. Facilities must demonstrate compliance with over 400 individual quality requirements covering premises, equipment, personnel, documentation, production, quality control, outsourced activities, complaints, and recalls.
Our Network of 30+ Certified Cultivators
Cannamedical Britannia sources exclusively from EU-GMP certified cultivators and manufacturers. Our supplier network spans more than 30 certified facilities across Europe and selected international markets, representing some of the most experienced and technically advanced medical cannabis producers in the world.
Each supplier in our network is subject to:
- Initial qualification audit — a comprehensive on-site review of quality management systems, production records, and facility standards before any product is approved for supply.
- Ongoing surveillance — regular remote and on-site monitoring to ensure continued compliance as regulations and best practices evolve.
- Batch-level certificate of analysis (CoA) — every batch supplied must be accompanied by a current CoA from an accredited third-party laboratory, confirming cannabinoid content, terpene profile, microbiological status, heavy metals, pesticide residues, and residual solvents are within specification.
Testing Standards
Medical cannabis products supplied by Cannamedical Britannia are tested against the following parameters as a minimum:
- Cannabinoid profile — HPLC or GC quantification of THC, CBD, CBN, CBG, THCA, CBDA, and other minor cannabinoids.
- Terpene profile — GC-MS analysis of major and minor terpenes for product characterisation and batch-to-batch consistency.
- Microbiological limits — total aerobic microbial count (TAMC), yeast and mould count (TYMC), absence of Salmonella and E. coli, and other specific pathogens per European Pharmacopoeia requirements.
- Heavy metals — arsenic, cadmium, lead, and mercury below EU pharmacopoeial limits.
- Pesticide residues — multi-residue screening against the EU maximum residue levels (MRL) list relevant to medicinal products.
- Residual solvents — for extracted products, ICH Q3C Class 1 and Class 2 solvent limits.
- Water content and water activity — to ensure microbiological stability throughout shelf life.
Why EU-GMP Matters for UK Patients
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) requires that unlicensed cannabis-based products for medicinal use (CBPMs) be manufactured to Good Manufacturing Practice standards. EU-GMP provides the internationally recognised framework that satisfies this requirement.
For patients, EU-GMP certification means:
- What is stated on the label matches what is in the product.
- The product is free from harmful contaminants.
- Every batch can be traced back to its origin and recalled if a quality issue is identified.
- The production facility has been independently audited by a regulatory authority.
Comparison: EU-GMP vs Unlicensed Products
Not all medical cannabis products available in the UK are produced to EU-GMP standards. Grey-market and unregulated products — even those marketed as “medical grade” — may carry significant risks including mislabelled cannabinoid content, pesticide and mould contamination, and inconsistent dosing. Cannamedical Britannia only supplies products that meet the highest pharmaceutical manufacturing standards, protecting both patients and prescribers.
Our Quality Commitment
Quality is one of the four core values of Cannamedical Britannia. It is not an afterthought — it is built into every stage of our supply chain. Learn more about our Quality Management System or access detailed product specifications in our clinician portal.